Related Experiment Video
Updated: Jun 6, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Risk of infective endocarditis in patients with mitral valve prolapse: Systematic review with meta-analysis
Luisa Marques1, Catarina de Sousa2,3, Fausto J Pinto2,3
1Faculdade de Medicina, Universidade de Lisboa, Portugal.
Aims:
Infective endocarditis (IE) is a serious heart valvular condition. While mitral valve prolapse (MVP) has been associated with an increased risk of IE, the magnitude of this association remains poorly quantified. This systematic review aimed to better estimate the risk of developing IE among MVP patients compared with the general population.
Methods:
MEDLINE, Cochrane Library (CENTRAL) and Web of Science databases were searched electronically to find all the relevant cohort and case-control studies. Pooled estimates of odds ratios (ORs) and 95 % confidence intervals (CIs) were derived by random effects meta-analysis. Heterogeneity was assessed using the I2 test.
Results:
A total of six studies were considered eligible, and the obtained results showed that MVP patients had a higher risk of IE when compared to the general population (OR 7.83, 95 % CI 5.11, 12.02; I2 = 0 %). Posterior analysis according to the risk of bias and study design didn't show any significant variations in the direction and magnitude of the effect.
Conclusion:
The magnitude of increased risk of IE of 7-fold warrants further attention for patients with MVP. Further contemporary studies and prophylaxis studies should be considered.
Insights
Patients with mitral valve prolapse (MVP) have a significantly higher risk of developing infective endocarditis (IE). This systematic review found a 7-fold increased risk, highlighting the need for increased attention and further research.
Area of Science:
- Cardiology
- Infectious Diseases
- Epidemiology
Background:
- Infective endocarditis (IE) is a severe valvular heart condition.
- Mitral valve prolapse (MVP) is a known risk factor for IE, but the exact magnitude of this association requires quantification.
Purpose of the Study:
- To systematically review and meta-analyze existing studies to estimate the risk of IE in patients with MVP compared to the general population.
- To provide a more precise quantification of the association between MVP and IE.
Main Methods:
- A systematic literature search was conducted across MEDLINE, Cochrane Library (CENTRAL), and Web of Science.
- Eligible cohort and case-control studies were included.
- Random effects meta-analysis was used to pool odds ratios (ORs) and 95% confidence intervals (CIs), with heterogeneity assessed by the I2 test.
Main Results:
- Six studies were included in the meta-analysis.
- MVP patients demonstrated a significantly higher risk of IE (OR 7.83, 95% CI 5.11–12.02).
- No significant variations in effect were observed based on risk of bias or study design.
Conclusions:
- The 7-fold increased risk of IE in MVP patients warrants significant clinical attention.
- Further contemporary research and studies on prophylaxis are recommended for this patient group.
More Related Videos
Related Concept Videos
Mitral Valve Prolapse I: Introduction
Mitral Stenosis I: Introduction
Mitral Valve Prolapse III: Nursing Management
Mitral Valve Prolapse II: Assessment and Management
Endocarditis I: Introduction
Mitral Regurgitation I: Introduction

